Gene editing for gene and cell therapy. Technologies, models and translation. The 1-day conference on Friday 23rd November 2018 aims to give the attendee an overview about the successes, challenges and areas for future development. The programme is exciting and key national and international speakers have accepted the invitation to speak at the conference. The
Lentviral and retroviral vectors are at the forefront of advanced therapeutic medicinal product (ATMP) development. The 1-day conference in April 2018 aims to give the attendee an overview about the successes, challenges and areas for future development.
Don’t miss this unique opportunity to participate in an intensive three day training course with workshops, sessions, catering and accommodation all under one roof in one of Oxford’s most beautiful colleges. Learn from and network with Britain’s and Europe’s current and future leaders in the fields of gene and cell therapy in the city of dreaming spires.
This free, one-day interactive event provides an opportunity to discuss and debate cutting edge research with scientists, patients, research students and clinicians/nurses, and to think about the impact that this research has on society and on you.
Dedicating to facilitating education, communication and the sharing of expertise and knowledge.
The aim of the British Society for Gene and Cell Therapy is to accelerate scientific progress and promote ethical and efficient transfer of gene- and cell-based technologies from the laboratory into the clinic.
Gene and cell therapy is an area where co-operation between ALL the interested parties - general public, patients, scientists, government and the media - is vital for the optimal development of these technologies and treatments, and BSGCT is working towards becoming this pro-active interface.